Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2001

01-04-2001 | Case Report

Antitumor Immunity Induced by Irradiated Tumor Cells Producing Macrophage Colony-Stimulating Factor

Authors: Shinya Suzu, Fumihiko Kimura, Miyuki Tanaka-Douzono, Muneo Yamada, Yukitsugu Nakamura, Naoki Wakimoto, Ken Sato, Toshiro Morita, Kazuma Ikeda, Kazuo Motoyoshi

Published in: International Journal of Hematology | Issue 3/2001

Login to get access
Metadata
Title
Antitumor Immunity Induced by Irradiated Tumor Cells Producing Macrophage Colony-Stimulating Factor
Authors
Shinya Suzu
Fumihiko Kimura
Miyuki Tanaka-Douzono
Muneo Yamada
Yukitsugu Nakamura
Naoki Wakimoto
Ken Sato
Toshiro Morita
Kazuma Ikeda
Kazuo Motoyoshi
Publication date
01-04-2001
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2001
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02981965

Other articles of this Issue 3/2001

International Journal of Hematology 3/2001 Go to the issue

OriginalPaper

Negative Regulators of Cytokine Signaling

Case Report

Long-Term Outcome of Treatment With Protocols AL841, AL851, and ALHR88 in Children With Acute Lymphoblastic Leukemia: Results Obtained by the Kyushu-Yamaguchi Children’s Cancer Study Group

OriginalPaper

Structural and Functional Hot Spots in Cytokine Receptors

Case Report

Analysis of Clonal Relationship Using Single-Cell Polymerase Chain Reaction in a Patient with Concomitant Mantle Cell Lymphoma and Multiple Myeloma

Letter to the Editor

Breast Carcinoma Presenting as Immune Thrombocytopenic Purpura

Case Report

Successful Combination Therapy—Flunarizine, Pentoxifylline, and Cholestyramine— for Spur Cell Anemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits